Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites

Chemical Research in Toxicology

Volumn 18, Issue 5, 2005, Pages 896-903

  Gan, Jinping ^a   Harper, Timothy W ^a   Hsueh, Mei Mann ^a   Qu, Qinling ^a   Humphreys, W Griffith ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; DANSYL CHLORIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; PULEGONE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION; COST EFFECTIVENESS ANALYSIS; DERIVATIZATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER MICROSOME; MASS SPECTROMETER; METABOLITE; OXIDATION; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; SENSITIVITY AND SPECIFICITY;

BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DANSYL COMPOUNDS; DINITROCHLOROBENZENE; FLUORESCENCE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; HUMANS; LIVER; MASS SPECTROMETRY; MONOTERPENES; OXIDATION-REDUCTION; SPECTROMETRY, FLUORESCENCE; SULFHYDRYL COMPOUNDS;

EID: 18944396519     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0496791     Document Type: Article

References (42)

1. Uetrecht, J. P. (1999) New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. Chem. Res. Toxicol. 12, 387-395.
2. Park, B. K., Kitteringham, N. R., Powell, H., and Pirmohamed, M. (2000) Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity. Toxicology 153, 39-60.
3. Li, A. P. (2002) A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity. Chem.-Biol. Interact. 142, 7-23.
4. Park, B. K., Kitteringham, N. R., Maggs, J. L., Pirmohamed, M., and Williams, D. P. (2005) The role of metabolic activation in drug-induced hepatotoxicity. Annu. Rev. Pharmacol. Toxicol. 45, 177-202.
5. Roth, R. A., Luyendyk, J. P., Maddox, J. F., and Ganey, P. E. (2003) Inflammation and drug idiosyncrasy-Is there a connection? J. Pharmacol. Exp. Ther. 307, 1-8.
6. Park, B. K., Naisbitt, D. J., Gordon, S. F., Kitteringham, N. R., and Pirmohamed, M. (2001) Metabolic activation in drug allergies. Toxicology 158, 11-23.
7. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A. (2004) Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17, 3-16.
8. Chen, W. G., Zhang, C., Avery, M. J., and Fouda, H. G. (2001) Reactive metabolite screen for reducing candidate attrition in drug discovery. Adv. Exp. Med. Biol. 500, 521-524.
9. Yan, Z., and Caldwell, G. W. (2004) Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature. Anal. Chem. 76, 6835-6847.
10. Boelsterli, U. A. (1993) Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury. Drug Metab. Rev. 25, 395-451.
11. Samuel, K., Yin, W., Stearns, R. A., Tang, Y. S., Chaudhary, A. G., Jewell, J. P., Lanza, T., Jr., Lin, L. S., Hagmann, W. K., Evans, D. C., and Kumar, S. (2003) Addressing the metabolic activation potential of new leads in drug discovery: A case study using ion trap mass spectrometry and tritium labeling techniques. J. Mass Spectrom. 38, 211-221.
12. Davis, W., Jr., Ronai, Z. E., and Tew, K. D. (2001) Cellular Thiols and Reactive Oxygen Species in Drug-Induced Apoptosis. J. Pharmacol. Exp. Ther. 296, 1-6.
13. Meister, A., and Anderson, M. E. (1983) Glutathione. Annu. Rev. Biochem. 52, 711-760.
14. Jean, P. A., and Roth, R. A. (1995) Naphthylisothiocyanate disposition in bile and its relationship to liver glutathione and toxicity. Biochem. Pharmacol. 50, 1469-1474.
15. Nash, J. A., King, L. J., Lock, E. A., and Green, T. (1984) The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. Toxicol. Appl. Pharmacol. 73, 124-137.
16. Dekant, W., Metzler, M., and Henschler, D. (1986) Identification of S-1,2,2-trichlorovinyl-N-acetylcysteine as a urinary metabolite of tetrachloroethylene: Bioactivation through glutathione conjugation as a possible explanation of its nephrocarcinogenicity. J. Biochem. Toxicol. 1, 57-72.
17. Mutlib, A. E., Gerson, R. J., Meunier, P. C., Haley, P. J., Chen, H., Gan, L. S., Davies, M. H., Gemzik, B., Christ, D. D., Krahn, D. F., Markwalder, J. A., Seitz, S. P., Robertson, R. T., and Miwa, G. T. (2000) The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats. Toxicol. Appl. Pharmacol. 169, 102-113.
18. Soglia, J. R., Harriman, S. P., Zhao, S., Barberia, J., Cole, M. J., Boyd, J. G., and Contillo, L. G. (2004) The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent. J. Pharm. Biomed. Anal. 36, 105-116.
19. Thompson, D. C., Perera, K., and London, R. (1995) Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: Relationship to toxicity. Chem. Res. Toxicol. 8, 55-60.
20. Jones, D. P., Carlson, J. L., Samiec, P. S., Sternberg, P., Jr., Mody, V. C., Jr., Reed, R. L., and Brown, L. A. (1998) Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta 275, 175-184.
21. Hammermeister, D. E., Serrano, J., Schmieder, P., and Kuehl, D. W. (2000) Characterization of dansylated glutathione, glutathione disulfide, cysteine and cystine by narrow bore liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 14, 503-508.
22. Nelson, S. D. (1995) Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab. Rev. 27, 147-177.
23. Khojasteh-Bakht, S. C., Chen, W., Koenigs, L. L., Peter, R. M., and Nelson, S. D. (1999) Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: Evidence for formation of a furan epoxide. Drug Metab. Dispos. 27, 574-580.
24. Maggs, J. L., Williams, D., Pirmohamed, M., and Park, B. K. (1995) The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. J. Pharmacol. Exp. Ther. 275, 1463-1475.
25. Liu, Z. C., and Uetrecht, J. P. (1995) Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. J. Pharmacol. Exp. Ther. 275, 1476-1483.
26. Tang, W., Stearns, R. A., Bandiera, S. M., Zhang, Y., Raab, C., Braun, M. P., Dean, D. C., Pang, J., Leung, K. H., Doss, G. A., Strauss, J. R., Kwei, G. Y., Rushmore, T. H., Chiu, S.-H. L., and Baillie, T. A. (1999) Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: Identification of glutathione conjugated metabolites. Drug Metab. Dispos. 27, 365-372.
27. Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., and Baillie, T. A. (2001) Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem. Res. Toxicol. 14, 62-70.
28. He, K., Talaat, R. E., Pool, W. F., Reily, M. D., Reed, J. E., Bridges, A. J., and Woolf, T. F. (2004) Metabolic activation of troglitazone: Identification of a reactive metabolite and mechanisms involved. Drug Metab. Dispos. 32, 639-646.
29. Tettey, J. N., Maggs, J. L., Rapeport, W. G., Pirmohamed, M., and Park, B. K. (2001) Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo. Chem. Res. Toxicol. 14, 965-974.
30. Buben, J. A., Narasimhan, N., and Hanzlik, R. P. (1988) Effects of chemical and enzymic probes on microsomal covalent binding of bromobenzene and derivatives. Evidence for quinones as reactive metabolites. Xenobiotica 18, 501-510.
31. Madhu, C., Klaassen, C. D., Buben, J. A., Narasimhan, N., and Hanzlik, R. P. (1992) Bromobenzene-glutathione excretion into bile reflects toxic activation of bromobenzene in rats. Toxicol. Lett. 60, 227-236.
32. Ravindranath, V., Boyd, M. R., and Jerina, D. M. (1987) Hepatotoxicity of precocene I in rats. Role of metabolic activation in vivo. Biochem. Pharmacol. 36, 441-446.
33. Sanger, F. (1988) Sequences, sequences, and sequences. Ann. Rev. Biochem. 57, 1-29.
34. Habig, W. H., Pabst, M. J., and Jakoby, W. B. (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139.
35. Rinaldi, R., Eliasson, E., Swedmark, S., and Morgenstern, R. (2002) Reactive intermediates and the dynamics of glutathione transferases. Drug Metab. Dispos. 30, 1053-1058.
36. Armstrong, R. N. (1997) Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol. 10, 2-18.
37. Gardner, I., Zahid, N., MacCrimmon, D., and Uetrecht, J. P. (1998) A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes. Mol. Pharmacol. 53, 991-998.
38. James, L. P., Mayeux, P. R., and Hinson, J. A. (2003) Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 31, 1499-1506.
39. Smith, M. T. (2003) Mechanisms of troglitazone hepatotoxicity. Chem. Res. Toxicol. 16, 679-687.
40. Graham, D. J., Drinkard, C. R., and Shatin, D. (2003) Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone. Am. J. Gastroenterol. 98, 175-179.
41. Boelsterli, U. A. (2003) Diclofenac-induced liver injury: A paradigm of idiosyncratic drug toxicity. Toxicol. Appl. Pharmacol. 192, 307-322.
42. Guest, I., Sokoluk, B., MacCrimmon, J., and Uetrecht, J. (1998) Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis. Toxicology 131, 53-65.